Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 123 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1221 9.9 months GBM 4 Biologic therapy
Duke University Medical Center United States 12/2008
Treatment Details: Patients: This phase 2 study involved 81 patients with recurrent glioblastoma multiforme. The median age was 52 years, ranging from 29 to 81. The majority (63%) were men. Treatment:
 
1222 9.9 months Newly diagnosed malignant glioma 4 Chemotherapy
Radiation
CHU de Nancy, Hôpital Central France 6/2009
Treatment Details: Patients: This phase 2 study involved 22 patients with newly diagnosed gliomas. There were 16 men and 6 women. The median age was 56, ranging from 32 to 74 years of age. Treatment: Pa
 
1223 9.9 months SCLC 4 Chemotherapy
St. Vincent's Hospital, The Catholic University of Korea Korea 9/2010
Treatment Details: Patients: This study involved 25 small-cell lung cancer patients who were in their second line of therapy after failing to respond to or progressed after prior treatment. The median age of
 
1224 9.8 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
Abramson Cancer Center, University of Pennsylvania United States 7/2011
Treatment Details: Patients: This phase II study involved 40 patients with advanced hepatocellular carcinoma who had not received prior chemotherapy. The median patient age was 56 years and 80% of the patien
 
1225 9.8 months NSCLC 5 Chemotherapy
National Cancer Center Singapore 7/2010
Treatment Details: Patients: This was a “2-arm” study in which patients with advanced non-small-cell lung cancer were separated into two treatment groups, called arm A and arm B. Arm A consisted of 190 patie
 
1226 9.8 months Advanced NSCLC 5 Chemotherapy
Gifu Municipal Hospital Japan 2/2006
Treatment Details: Patients: This Phase II study involved 61 patients (46 men, 15 women, median age 65 years) with advanced non-small-cell lung cancer. None of the patients had received treatment before the s
 
1227 9.8 months advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Campus Bio-Medico University Italy 2/2006
Treatment Details: Patients: This Phase II study involved 55 patients (21 men, 34 women, median age 63 years) with advanced colorectal cancer. All patients had previously received chemotherapy prior to the st
 
1228 9.8 months Advanced NSCLC 4 Chemotherapy
Bellaria Hospital Italy 6/2006
Treatment Details: Patients: This Phase II trial involved a total of 117 patients with advanced non-small-cell lung cancer. There were 98 men and 19 women. Seventy-nine patients had stage IV disease and 39 p
 
1229 9.8 months Advanced or recurrent NSCLC 5 Chemotherapy
University of Torino Italy 11/2002
Treatment Details: Patients: This Phase III study involved a total of 607 patients with advanced (stage IIIB or IV or recurrent) non-small cell lung cancer. Patients were divided into three groups. Group A c
 
1230 9.8 months Advanced NSCLC 4 Chemotherapy
Hygeia Hospital Greece 9/2002
Treatment Details: Patients: This Phase III study involved 509 patients with advanced (stages IIIA, IIIB, and IV) non-small-cell lung cancer. None of the patients had been administered prior chemotherapy. Pa
 
Page 123 of 187  | Previous Page  | Next Page